Financials • Life Insurance
$3.86 ▲ +0.06
(+1.58%)
MKT CAP: $195.5M • VOL: 120.8K
52W L $3 52W H $7
ROARABLE / RQD
C- • 59/100
PIOTROSKI
3 / 9
CIA // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $255.6M | $245.0M | $240.7M |
| YoY Revenue Growth % | +4.3% | +1.8% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $0 | $0 | $0 |
| Operating Margin % | — | — | — |
| Net Income (GAAP) | $0 | $0 | $0 |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $18.0M | $31.9M | $22.1M |
| Capital Expenditures (CapEx) | $447.0K | $663.0K | — |
| Free Cash Flow (FCF) | $17.5M | $31.3M | $22.1M |
| FCF Margin % | 6.9% | 12.8% | 9.2% |
| Return on Invested Capital (ROIC %) | — | — | — |
| Cash & Short-Term Equivalents | $23.0M | $29.3M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $235.0M | $210.4M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR CIA.